Beta Bionics Inc

BBNXNASDAQ · USD
22.81USD0.00 (+3.50%)
3510

Beta Bionics Inc (BBNX) Option Chain

As of September 22, 2026, Beta Bionics Inc is trading at $22.81, a +3.50% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 104.0%. IV Rank is —%.

Read more

Tracking the BBNX option chain helps you see every strike and expiry on Beta Bionics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Beta Bionics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of BBNX options activity at a glance. Use our scanner to monitor the BBNX option chain in real time and filter for the BBNX options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For BBNX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the BBNX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where BBNX stock options are being actively traded and where they are not.

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes.

It has collaboration and license agreement with Xeris Pharmaceuticals, Inc. (Xeris) to develop and commercialize a pump-compatible glucagon formulation; and development and commercialization agreement with Abbott Diabetes Care Inc. to develop and commercialize an automated insulin delivery system. The company was incorporated in 2015 and is based in Irvine, California.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Beta Bionics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen BBNX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of BBNX stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryMedical Devices
  • SectorHealthcare
  • IV percentile
  • Market cap (M$)1,231
  • 52 weeks high-30.27%
  • 52 weeks low159.20%
  • Analyst recommendationBuy
    1.67
  • Target price$22.40
    -1.80% below the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-10-27
  • P/E
  • Future P/E
  • EPS (ttm)-1.65
  • EPS growth next 5 years3.73%

As of September 22, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
12.402120-0.517.815.908.7015.00-31.943.500.003.500187.60
26.221800.145.313.607.3017.50-20.600.301.250.000.782173.78
42.57110.742.812.404.7020.00-9.260.254.000.002.131057.43
58.283452.720.311.055.0022.50+2.090.154.500.002.330041.72
71.35503.900.003.9025.00+13.431.554.902.191.030028.65

As of September 22, 2026

Scan the full option chain in one place

Browse the full BBNX option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial